Funded Health Care Startups in Singapore
Recent funded health care rounds in Singapore span 2020-05-20 (OBVIOHEALTH, $17M) through 2025-06-25 (Elfie, $12M), with the dataset showing 28 entries.
Recent funded health care rounds in Singapore span 2020-05-20 (OBVIOHEALTH, $17M) through 2025-06-25 (Elfie, $12M), with the dataset showing 28 entries. A clear comparative outlier appears on the disclosed side: Jubilant Pharma’s $400M debt financing on 2022-07-13 dwarfs the next-largest disclosed rounds such as Doctor Anywhere’s $59M (2021-08-24) and ABM Respiratory Care’s $15M (2025-06-17), while most disclosed amounts cluster in the single-digit millions (for example, Biorithm $4M on 2023-12-18, Origin Health $3M on 2023-05-12).
Stage labeling is also mixed: “Series Unknown” or blank appears in multiple rows (counting SynPhNe 2024-03-11, Mobio Interactive 2023-08-16, AP Technologies 2023-08-10, Quadria Capital 2023-08-10, Beyond Medical Group 2022-10-26, MiyaHealth 2022-08-17, Mednefits 2020-11-17, dClinic.co 2020-11-11, See-Mode Technologies 2020-08-20, OBVIOHEALTH 2020-05-20, plus Speedoc’s “Venture - Series Unknown” on 2022-10-01), and “undisclosed” amounts occur alongside some named rounds (e.g., JioVio 2023-12-25, WhiteCoat 2023-09-07). Geographically, every entry is within Singapore’s Central Region, Singapore (same city-level label across the list).
Most recent rounds
28 shownRelated listings
Frequently asked
What are the largest and smallest disclosed rounds in this Singapore health care list, and how extreme is the gap?
The largest disclosed amount is Jubilant Pharma’s $400M debt financing on 2022-07-13, which dwarfs the next-largest disclosed rounds (Doctor Anywhere $59M on 2021-08-24 and ABM Respiratory Care $15M on 2025-06-17). The smallest disclosed amount shown is Adravision’s $100K on 2024-02-08.
Do any rounds cluster in a narrow time window, or are they spread evenly across years?
While dates span 2020-05-20 to 2025-06-25, there are multiple entries in 2022 (for example: Jubilant Pharma 2022-07-13 $400M; AMILI 2022-06-15 $11M; HealthBeats 2022-04-28 $3M), and several additional entries fall in 2023 (e.g., ThoughtFull 2023-03-23 $4M and NOVI Health 2022-11-23 $5M are nearby in the same broader run).
Which stage labels dominate, and what share of rounds have missing or non-numeric amounts?
Stage text is split between named rounds (e.g., Series A: Elfie 2025-06-25 $12M; Series B: ABM Respiratory Care 2025-06-17 $15M; Series C: Doctor Anywhere 2021-08-24 $59M) and multiple “Series Unknown”/blank classifications (SynPhNe 2024-03-11; Mobio Interactive 2023-08-16; Beyond Medical Group 2022-10-26; Mednefits 2020-11-17; dClinic.co 2020-11-11; See-Mode Technologies 2020-08-20; OBVIOHEALTH 2020-05-20). Separately, “undisclosed” amounts appear on JioVio 2023-12-25, WhiteCoat 2023-09-07, and multiple others.
Are there clear outliers besides the $400M debt round?
Yes: Doctor Anywhere’s $59M on 2021-08-24 is a notable high end above many single-digit disclosed amounts (such as HealthBeats $3M on 2022-04-28 and Respiree $4M on 2022-03-09). On the low end, Adravision’s $100K (2024-02-08) is far below the next small disclosed figures like Oncoshot’s $900K (2022-10-13).
Is there a consistent geographic pattern across companies, or do locations vary within Singapore?
Every listed company uses the same city-level label: “Singapore, Central Region, Singapore.” There are no alternate city or region labels within this 28-row view (all entries map to Central Region, Singapore).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.